Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 459

1.

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus.

Smith KJ, O'Brien SM, Smithers BM, Gotley DC, Webb PM, Green AC, Whiteman DC.

Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2481-6.

2.

Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-Based Case-Control Study.

Lindam A, Kendall BJ, Thrift AP, Macdonald GA, O'Brien S, Lagergren J, Whiteman DC.

PLoS One. 2015 Jun 19;10(6):e0129836. doi: 10.1371/journal.pone.0129836.

3.

A pilot study of the association of low plasma adiponectin and Barrett's esophagus.

Rubenstein JH, Dahlkemper A, Kao JY, Zhang M, Morgenstern H, McMahon L, Inadomi JM.

Am J Gastroenterol. 2008 Jun;103(6):1358-64. doi: 10.1111/j.1572-0241.2008.01823.x.

PMID:
18510610
4.

Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.

Cook MB, Shaheen NJ, Anderson LA, Giffen C, Chow WH, Vaughan TL, Whiteman DC, Corley DA.

Gastroenterology. 2012 Apr;142(4):744-53. doi: 10.1053/j.gastro.2011.12.049.

5.

Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma.

Mulholland HG, Cantwell MM, Anderson LA, Johnston BT, Watson RG, Murphy SJ, Ferguson HR, McGuigan J, Reynolds JV, Comber H, Murray LJ.

Cancer Causes Control. 2009 Apr;20(3):279-88. doi: 10.1007/s10552-008-9242-6.

PMID:
18839322
6.

Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.

Vaughan TL, Kristal AR, Blount PL, Levine DS, Galipeau PC, Prevo LJ, Sanchez CA, Rabinovitch PS, Reid BJ.

Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):745-52.

7.
8.

The real value of lower esophageal sphincter measurement for predicting acid gastroesophageal reflux or Barrett's esophagus.

Alonso O, Hernández D, Moreno E, Manrique A, Moreno A, García-Sesma A, Calvo J.

J Gastrointest Surg. 2005 Sep-Oct;9(7):973-9.

PMID:
16137594
9.
10.

Gallstones increase the prevalence of Barrett's esophagus.

Matsuzaki J, Suzuki H, Asakura K, Saito Y, Hirata K, Takebayashi T, Hibi T.

J Gastroenterol. 2010 Feb;45(2):171-8. doi: 10.1007/s00535-009-0153-4.

PMID:
19908109
11.
12.

Association between gastroesophageal flap valve, reflux esophagitis, Barrett's epithelium, and atrophic gastritis assessed by endoscopy in Japanese patients.

Fujiwara Y, Higuchi K, Shiba M, Watanabe T, Tominaga K, Oshitani N, Matsumoto T, Arakawa T.

J Gastroenterol. 2003;38(6):533-9.

PMID:
12825128
13.

A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.

Dai JY, de Dieu Tapsoba J, Buas MF, Onstad LE, Levine DM, Risch HA, Chow WH, Bernstein L, Ye W, Lagergren J, Bird NC, Corley DA, Shaheen NJ, Wu AH, Reid BJ, Hardie LJ, Whiteman DC, Vaughan TL.

Cancer Epidemiol Biomarkers Prev. 2015 Nov;24(11):1739-47. doi: 10.1158/1055-9965.EPI-15-0507.

14.

Prevalence of Barrett's esophagus in the general population: an endoscopic study.

Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agréus L.

Gastroenterology. 2005 Dec;129(6):1825-31.

PMID:
16344051
15.

Prediction of Barrett's esophagus among men.

Rubenstein JH, Morgenstern H, Appelman H, Scheiman J, Schoenfeld P, McMahon LF Jr, Metko V, Near E, Kellenberg J, Kalish T, Inadomi JM.

Am J Gastroenterol. 2013 Mar;108(3):353-62. doi: 10.1038/ajg.2012.446.

16.

Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?

Gough MD, Ackroyd R, Majeed AW, Bird NC.

Am J Gastroenterol. 2005 May;100(5):1012-8.

PMID:
15842572
17.

Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.

Brown CS, Lapin B, Wang C, Goldstein JL, Linn JG, Denham W, Haggerty SP, Talamonti MS, Howington JA, Carbray J, Ujiki MB.

Surg Endosc. 2015 Dec;29(12):3528-34. doi: 10.1007/s00464-015-4103-3.

PMID:
25676204
18.

Gastric surgery is not a risk factor for the development or progression of Barrett's epithelium.

Akiyama T, Inamori M, Akimoto K, Iida H, Mawatari H, Endo H, Nozaki Y, Yoneda K, Ikeda T, Sakamoto Y, Fujita K, Yoneda M, Takahashi H, Goto A, Hirokawa S, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Rino Y, Nakajima A.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1899-904.

PMID:
19102418
19.

Short segment Barrett's esophagus and distal gastric intestinal metaplasia.

Dietz J, Chaves-E-Silva S, Meurer L, Sekine S, de Souza AR, Meine GC.

Arq Gastroenterol. 2006 Apr-Jun;43(2):117-20.

20.

GERD and Barrett's esophagus: diagnostic and management strategies in the geriatric population.

Morganstern B, Anandasabapathy S.

Geriatrics. 2009 Jul;64(7):9-12.

PMID:
19586085
Items per page

Supplemental Content

Support Center